Have a personal or library account? Click to login
Use of standard laboratory methods to obviate routine dithiothreitol treatment of blood samples with daratumumab interference Cover

Use of standard laboratory methods to obviate routine dithiothreitol treatment of blood samples with daratumumab interference

Immunohematology
Volume 33 (2017): Issue 1 (March 2017)
By: N.J. Lintel,  D.K. Brown,  D.T. Schafer,  F.M. Tsimba-Chitsva,  S.A. Koepsell and  S.M. Shunkwiler  
Paid access
|Oct 2019

Authors

N.J. Lintel

nicholas.lintel@unmc.edu

House Officer II, University of Nebraska Medical Center, Department of Pathology and Microbiology, Omaha, NE, United States

D.K. Brown

Blood Bank Manager, Nebraska Medicine, Department of Transfusion and Transplant, Omaha, NE, United States

D.T. Schafer

Blood Bank Manager, Nebraska Medicine, Department of Transfusion and Transplant, Omaha, NE, United States

F.M. Tsimba-Chitsva

Technologist III, IRL, American Red Cross, Western Blood Services Division, Midwest Region, Omaha, NE, United States

S.A. Koepsell

University of Nebraska Medical Center, Department of Pathology and Microbiology, Omaha, NE., United States

S.M. Shunkwiler

University of Nebraska Medical Center, Department of Pathology and Microbiology, Omaha, NE., United States
DOI: https://doi.org/10.21307/immunohematology-2019-005 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Journal RSS Feed
Language: English
Page range: 22 - 26
Published on: Oct 9, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
daratumumab,
pre-transfusion testing,
interference
Related subjects:
Medicine,
Clinical medicine,
Laboratory medicine

© 2019 N.J. Lintel, D.K. Brown, D.T. Schafer, F.M. Tsimba-Chitsva, S.A. Koepsell, S.M. Shunkwiler, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous articleVolume 33 (2017): Issue 1 (March 2017)Next article